Adding stereotactic ablative radiotherapy (SAbR) to neoadjuvant chemotherapy improves pathologic outcomes for patients ...

SGLT2 inhibitors and GLP-1 receptor agonists lower cardiovascular risk in type 2 diabetes, but a recent review suggests that ...

Researchers have found in a recent study that weight loss and lowering blood sugar levels lower significantly the all-cause ...

The FDA has accepted for priority review a new supplemental biologics license application for Winrevair to treat adults with ...

Women with cardiovascular disease (CVD) have a substantially higher adiposity-associated risk for breast cancer.